1. Home
  2. SSM vs MBAI Comparison

SSM vs MBAI Comparison

Compare SSM & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SSM

Sono Group N.V. Ordinary Shares

N/A

Current Price

$5.23

Market Cap

10.6M

Sector

N/A

ML Signal

N/A

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$1.40

Market Cap

12.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SSM
MBAI
Founded
2016
2004
Country
Germany
Israel
Employees
43
85
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
12.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SSM
MBAI
Price
$5.23
$1.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
64.2K
102.5K
Earning Date
05-20-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1,462,987.20
N/A
Revenue Next Year
$48.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.34
$1.29
52 Week High
$10.54
$3.92

Technical Indicators

Market Signals
Indicator
SSM
MBAI
Relative Strength Index (RSI) 33.00 35.83
Support Level N/A $1.31
Resistance Level $7.43 $1.83
Average True Range (ATR) 0.76 0.11
MACD -0.08 -0.03
Stochastic Oscillator 12.22 13.53

Price Performance

Historical Comparison
SSM
MBAI

About SSM Sono Group N.V. Ordinary Shares

Sono Group NV is engaged in the field of solar-powered electric mobility. With its proprietary solar technology, the company is able to integrate solar panels into a vehicle's bodywork, using energy captured from the sun to charge the vehicle's battery. The group is engaged in the design and development of its own first solar electric vehicle, the Sion. Its Products and Services includes Complete Solar Solutions, Solar Charge Controllers, Solar Modules, and Data Services and Engineering Services.

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: